Extensive thrombotic purpura revealing multiple myeloma associated – type I cryoglobulinemia
Hypercalcaemia in diffuse large B-cell lymphoma with expression of both parathyroid hormone-related protein and its receptor
The clinical management of tumour lysis syndrome in haematological malignancies
Autoimmune cytopenia in chronic lymphocytic leukaemia: diagnosis and treatment
Review of the cardiac long-term effects of therapy for Hodgkin lymphoma
Guidelines for the diagnosis and management of multiple myeloma 2011
Guidelines for supportive care in multiple myeloma 2011
A steroid-independent regimen of bortezomib, liposomal doxorubicin and thalidomide demonstrate high response rates in newly diagnosed multiple myeloma patients
Targeting cell surface β2-microglobulin by pentameric IgM antibodies
Disabled-2 modulates homotypic and heterotypic platelet interactions by binding to sulfatides
Chromosome damage and repair in children with sickle cell anaemia and long-term hydroxycarbamide exposure
Response to 5-azacytidine in a patient with relapsed Hodgkin Lymphoma and a therapy-related myelodysplastic syndrome
Long term outcome of patients with steroid-refractory acute intestinal graft versus host disease after treatment with pentostatin
Influence of 6q22–23 on overall survival in primary central nervous system lymphoma. Analysis of North Central Cancer Treatment Group trials 86 72 52, 93 73 51 and 96 73 51
Third-party virus-specific T cells eradicate adenoviraemia but trigger bystander graft-versus-host disease
Hypomethylation of PRAME promoter is associated with poor prognosis in myelodysplastic syndrome
Corrigendum
Corrigendum